- Tytuł:
- Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada
- Autorzy:
- Źródło:
- PharmacoEconomics. 42(1):69-90
Czasopismo naukowe